| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67877-474-60 | 67877-474 | HUMAN PRESCRIPTION DRUG | Dabigatran Etexilate | Dabigatran Etexilate | CAPSULE, COATED PELLETS | ORAL | 20220620 | N/A | ANDA | ANDA208040 | Ascend Laboratories, LLC | DABIGATRAN ETEXILATE MESYLATE | 75 mg/1 | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60) |
| 67877-475-60 | 67877-475 | HUMAN PRESCRIPTION DRUG | Dabigatran Etexilate | Dabigatran Etexilate | CAPSULE, COATED PELLETS | ORAL | 20220620 | N/A | ANDA | ANDA208040 | Ascend Laboratories, LLC | DABIGATRAN ETEXILATE MESYLATE | 150 mg/1 | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-475-60) |